Research Alliance Corp. II (RACB)
|Net Income (ttm)||n/a|
|Trading Day||June 15|
|Day's Range||10.00 - 10.02|
|52-Week Range||9.70 - 11.33|
INDIANAPOLIS--(BUSINESS WIRE)--POINT Biopharma Inc. (POINT), a radiopharmaceutical company dedicated to bringing the many benefits of precision radioligand therapy to cancer patients, announced today th...
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Research Alliance Corp. I - RACA
NEW YORK, March 27, 2021 /PRNewswire/ -- Juan Monteverde , founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018 and 2019 ISS Securities Class ...
Research Alliance Corp. II, Sponsored by RA Capital Management, L.P., Announces Closing of $149.5 Million Initial Pub...
LAS VEGAS--(BUSINESS WIRE)--Research Alliance Corp. II (Nasdaq:RACB) (the “Company”) announced today that on March 22, 2021 it closed its initial public offering of 14,950,000 shares of Class A common s...
Research Alliance Corp. II, Sponsored by RA Capital Management, L.P., Announces Pricing of $130 Million Initial Publi...
Research Alliance Corp. II (the “Company”) announced today that it priced its initial public offering of 13,000,000 shares of Class A common stock at $10.00 per share.
Research Alliance II, the second blank check company formed by RA Capital targeting the biotech industry, filed on Tuesday with the SEC to raise up to $130 million in an initial public offering.
Research Alliance Corp. II has filed to go public with an IPO on the NASDAQ.
Research Alliance II is a newly organized blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. We intend to focus on industries that complement our management team’s background, and to capitalize on the ability of our management team to identify and acquire a business, focusing on the healthcare industry, with an emphasis on the biotechnology sector where our management has extensive investment ex... [Read more...]
|IPO Date |
Mar 18, 2021
Peter Kolchinsky, Ph.D.
|Stock Exchange |
|Ticker Symbol |